STERIS plc (STE)
STERIS is a behind-the-scenes healthcare giant that keeps medical equipment sterile and safe for hospitals and labs worldwide.
Is STERIS plc a good stock for a UK beginner?
The honest version: STERIS is a behind-the-scenes healthcare giant that keeps medical equipment sterile and safe for hospitals and labs worldwide.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Ageing populations driving a long-term increase in medical procedures.
Major shifts in healthcare technology making current sterilisation methods obsolete.
What does STERIS plc do?
STERIS provides the essential cleaning, sterilisation, and surgical support services that hospitals rely on every single day to keep patients safe. What brings in the money is selling specialised equipment and chemical cleaners, plus providing ongoing maintenance services to healthcare facilities. Their challenge is handling the rising costs of these complex operations without alienating the hospital clients they serve.
On our factor screen it looks strongest on growth and income, and weakest on momentum.
- ✓Pays a dividend - about 1.1% a year
- ✓Growing - revenue up about 7% over the year
- ✓Low debt - a sturdier balance sheet
- Essential services that hospitals cannot easily do without
- Strong gross margins indicating a solid competitive position
- Significant recent growth in earnings
- Changes in government healthcare policy affecting hospital funding
- Supply chain disruptions impacting the delivery of specialised equipment
- Potential for new, cheaper sterilisation technologies to enter the market
What do STERIS plc's numbers mean?
How much money does STERIS plc make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Does STERIS plc pay a dividend?
Yes - STERIS plc currently pays a dividend of about 1.1% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
When does STERIS plc report earnings, and how did recent quarters go?
STERIS plc is next scheduled to report on about 2026-08-05 - dates can move, and we don't predict results; this just tells you when to look.
Each quarter a company reports its results against what analysts expected. ‘Beating’ or ‘missing’ is about that expectation, not whether the business is doing well in absolute terms.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-05-11 | $2.85 | $2.83 | In line |
| 2026-02-04 | $2.53 | $2.53 | In line |
| 2025-11-05 | $2.35 | $2.47 | Beat +5% |
| 2025-08-06 | $2.26 | $2.34 | Beat +3% |
| 2025-05-14 | $2.60 | $2.74 | Beat +5% |
| 2025-02-05 | $2.32 | $2.32 | In line |
Across the last 6 quarters here, STERIS plc came in ahead of what analysts expected 3 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Reported vs expected earnings per share (EPS) from published results; the expectation is the analyst consensus, not our view. Report dates are estimates that can move.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for STERIS plc?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of STERIS plc?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Essential services that hospitals cannot easily do without
- Strong gross margins indicating a solid competitive position
- Significant recent growth in earnings
- Share price has struggled slightly over the past year
- Relies heavily on hospital budgets which can be unpredictable
- Moderate dividend yield may not satisfy income-focused investors
- Changes in government healthcare policy affecting hospital funding
- Supply chain disruptions impacting the delivery of specialised equipment
- Potential for new, cheaper sterilisation technologies to enter the market
The write-up's own warning lights — if these start happening, the case above changes.
- A sustained drop in the number of global surgical procedures
- A significant and permanent decline in hospital capital expenditure budgets
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.